Novocure (NVCR) Fundamental Analysis: Revenue, Earnings & Valuation

1.13 / 10

Underperform

Fundamental analysis rates NVCR as Underperform with a 1.1/10 quality score. Profit‑MV and Cash‑UP are modestly positive, while Cash‑MV, ROE and other profitability metrics are negative, indicating poor overall financial health.

Analysis Checks(5/10)

ROA (%)

Value-13.32

Score2/3

Weight-10.42%

1M Return0.63%

Annualized return on equity (%)

Value-38.89

Score1/3

Weight28.70%

1M Return-2.02%

Profit-MV

Value0.68

Score2/3

Weight-57.91%

1M Return3.26%

Cash-UP

Value-0.16

Score2/3

Weight52.81%

1M Return-3.92%

Annualized net profit margin on total assets (%)

Value-13.32

Score2/3

Weight-10.42%

1M Return0.63%

ROE (diluted) (%)

Value-40.01

Score1/3

Weight20.12%

1M Return-1.41%

Asset-MV

Value-0.55

Score1/3

Weight-10.95%

1M Return0.71%

ROE (%)

Value-38.89

Score1/3

Weight28.70%

1M Return-2.02%

Cash-MV

Value0.03

Score1/3

Weight45.53%

1M Return-3.56%

Net profit / Total profit (%)

Value99.98

Score2/3

Weight13.84%

1M Return-0.89%

Is NVCR undervalued or overvalued?

NVCR scores 1.13/10 on fundamentals and holds a Premium valuation at present. Backed by its -38.89% ROE, -20.79% net margin, -9.82 P/E ratio, 3.93 P/B ratio, and 21.79% earnings growth, these metrics solidify its Underperform investment rating.